Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Anna Keib"'
Autor:
Maria-Luisa Schubert, Anita Schmitt, Angela Hückelhoven-Krauss, Brigitte Neuber, Alexander Kunz, Philip Waldhoff, Dominik Vonficht, Schayan Yousefian, Lea Jopp-Saile, Lei Wang, Felix Korell, Anna Keib, Birgit Michels, Dominik Haas, Tim Sauer, Patrick Derigs, Andreas Kulozik, Joachim Kunz, Petra Pavel, Sascha Laier, Patrick Wuchter, Johann Schmier, Gesine Bug, Fabian Lang, Nicola Gökbuget, Jochen Casper, Martin Görner, Jürgen Finke, Andreas Neubauer, Mark Ringhoffer, Denise Wolleschak, Monika Brüggemann, Simon Haas, Anthony D. Ho, Carsten Müller-Tidow, Peter Dreger, Michael Schmitt
Publikováno v:
Journal of Hematology & Oncology, Vol 16, Iss 1, Pp 1-17 (2023)
Abstract Background Third-generation chimeric antigen receptor (CAR)-engineered T cells (CARTs) might improve clinical outcome of patients with B cell malignancies. This is the first report on a third-generation CART dose-escalating, phase-1/2 invest
Externí odkaz:
https://doaj.org/article/26e8df351a78481d84b79ca3e21d57c8
Autor:
Franziska Eberhardt, Angela Hückelhoven‑Krauss, Alexander Kunz, Genqiao Jiang, Tim Sauer, Avinoam Reichman, Brigitte Neuber, Kathrin Böpple, Anita Schmitt, Carsten Müller‑Tidow, Michael Schmitt, Anna Keib
Publikováno v:
International Journal of Molecular Medicine. 52
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7eab4bb61bc65381b2c81d42f2fcf2d
https://doi.org/10.3892/ijmm.2023.5261
https://doi.org/10.3892/ijmm.2023.5261
Autor:
Yibin Liu, Anna Keib, Brigitte Neuber, Lei Wang, Angelika B. Riemer, Maria Bonsack, Angela Hückelhoven-Krauss, Anita Schmitt, Carsten Müller-Tidow, Michael Schmitt
Publikováno v:
International Journal of Molecular Sciences
Volume 24
Issue 3
Pages: 1943
Volume 24
Issue 3
Pages: 1943
The transcription factor SOX11 is a tumor-associated antigen with low expression in normal cells, but overexpression in glioblastoma (GBM). So far, conventional surgery, chemotherapy, and radiotherapy have not substantially improved the dismal progno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::878dd02dee80daede0b8264e9f95f7ca
Autor:
Avinoam Reichman, Alexander Kunz, Jara J. Joedicke, Uta E. Höpken, Anna Keib, Brigitte Neuber, David Sedloev, Lei Wang, Genqiao Jiang, Angela Hückelhoven-Krauss, Franziska Eberhardt, Carsten Müller-Tidow, Martin Wermke, Armin Rehm, Michael Schmitt, Anita Schmitt
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences; Volume 23; Issue 2; Pages: 903
International Journal of Molecular Sciences, Vol 23, Iss 903, p 903 (2022)
International Journal of Molecular Sciences; Volume 23; Issue 2; Pages: 903
International Journal of Molecular Sciences, Vol 23, Iss 903, p 903 (2022)
Chimeric-antigen-receptor (CAR)-T-cell therapy is already widely used to treat patients who are relapsed or refractory to chemotherapy, antibodies, or stem-cell transplantation. Multiple myeloma still constitutes an incurable disease. CAR-T-cell ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f8a0cbfb6e770c9fca37cf99a8206bb
https://pubmed.ncbi.nlm.nih.gov/35055086
https://pubmed.ncbi.nlm.nih.gov/35055086
Publikováno v:
The Journal of Immunology. 202:618-624
Adenoviruses are a major cause of infectious mortality in children following allogeneic hematopoietic stem cell transplantation, with adoptive transfer of adenovirus-specific T cells being an effective therapeutic approach. We have previously shown t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c72e59e689f284d27dc965575ef05437
https://doi.org/10.4049/jimmunol.1801003
https://doi.org/10.4049/jimmunol.1801003
Autor:
Anna Keib, Michael Neuenhahn, Gerhard Jahn, Benjamin Faist, Patrick Günther, Anne Halenius, Kevin M. Dennehy, Dirk H. Busch
Publikováno v:
Viral Immunology. 30:149-156
Infection with adenovirus is a major cause of infectious mortality in children following hematopoietic stem-cell transplantation. While adoptive transfer of epitope-specific T cells is a particularly effective therapeutic approach, there are few suit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcef2683ba5ad3e4e7dae4d99ba2e405
https://doi.org/10.1089/vim.2016.0145
https://doi.org/10.1089/vim.2016.0145